Adage Capital Partners’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13M | Buy |
+603,800
| New | +$13M | 0.02% | 558 |
|
|
2023
Q3 | – | Sell |
-3,553,093
| Closed | -$85.1M | – | 863 |
|
|
2023
Q2 | $85.1M | Buy |
3,553,093
+2,328,093
| +190% | +$55.8M | 0.18% | 132 |
|
|
2023
Q1 | $23.1M | Buy |
+1,225,000
| New | +$23.1M | 0.05% | 379 |
|
|
2021
Q1 | – | Sell |
-80,000
| Closed | -$4.28M | – | 953 |
|
|
2020
Q4 | $4.28M | Buy |
+80,000
| New | +$4.28M | 0.01% | 703 |
|
|
2016
Q2 | – | Sell |
-259,800
| Closed | -$7.26M | – | 681 |
|
|
2016
Q1 | $7.26M | Buy |
+259,800
| New | +$7.26M | 0.02% | 567 |
|